还珠格格

官方：阿贾克斯20岁青训小将范德帕弗特将从坎布尔回归球队_我的网站

A |     8月26日讯 今天，阿贾克斯在俱乐部官网宣布，球队20岁青训小将范德帕弗特将从坎布尔回归阿贾克斯。阿贾克斯与坎布尔就瑞安·范德帕弗特回归一事达成协议，这名20岁的后卫此前租借效力于这支荷甲球队，如今将即刻返回阿贾克斯，范德帕弗特与阿贾克斯的合同有效期至2029年6月30日。    Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。

B | 范德帕弗特说道：“受个人情况影响，近几个月的发展并未达到我的预期。经过友好沟通，我们认定现阶段回到阿贾克斯是适合我的选择。我十分感谢坎布尔给予我的机会、对我的信任，以及我在这里受到的善待，祝愿俱乐部未来一切顺利。

C | ”范德帕弗特2006年1月24日出生于阿姆斯特丹，自2017年起加入阿贾克斯青训营，范德帕弗特回归后将进入阿贾克斯U23梯队。

Current article:http://vbq.wengsengzhanhuangu.cyou/news/20260826_39554.html

Published on:00:00:00